{"id":43550,"date":"2026-08-03T14:02:05","date_gmt":"2026-08-03T14:02:05","guid":{"rendered":"https:\/\/eurekainfomed.it\/en\/?p=43550"},"modified":"2026-08-03T14:02:05","modified_gmt":"2026-08-03T14:02:05","slug":"pharmacovigilance-outsourcing-for-pharmaceutical-companies","status":"publish","type":"post","link":"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/","title":{"rendered":"Pharmacovigilance outsourcing for pharmaceutical companies"},"content":{"rendered":"<p>A report of a suspected adverse reaction is never just a piece of data to be entered into a system. It may come from a physician, a patient, a digital channel, or a distributor, and it must be assessed, coded, followed up, and managed within defined timelines.<\/p>\n<div>\n<div id=\"copilot-message-rca\" class=\"fai-CopilotMessage__content r1izxv8h ___7qar2c0 fcthzvy\" dir=\"auto\">\n<div dir=\"auto\">\n<div class=\"___1vve6yh f22iagw f1vx9l62 f122n59 f3bhgqh f1mnxvew fly5x3f\">\n<div class=\"___j4vmuw0 f22iagw f1vx9l62 f1869bpl fly5x3f fbc6vix\">\n<div tabindex=\"-1\" data-testid=\"loading-message\">\n<div id=\"response-idrc8\" class=\"___1yop6mf f336tjw f9ijwd5 fz7g6wx fod5ikn f1s184ao\" data-testid=\"lastChatMessage\">\n<div class=\"___1peis63 f22iagw f1063pyq f6jr5hl f1c88k3p\">\n<div class=\"___4htdyp0 fz7g6wx fy77jfu\">\n<div class=\"___1j4t0a1 f1lmfglv f1abmfm4\" dir=\"auto\" aria-hidden=\"false\" data-testid=\"markdown-reply\" data-message-type=\"Chat\">\n<div class=\"___nfp7g60 f22iagw f1vx9l62 fkmyikg fk15e71 f1k953kz f137keqj f1rncccw f1stllg3 f1w4kmmc f1tric3v f10dk5ic fx8cdsv f16nlwsl f1eookvz fhjrts3 fqugt2f f18d18k8 f1v1vhmp f1hdmul3 f198vjnp f2dshw1 fjpjndq fnmj2pj ffrrb40 f1mon110 fhajzam fimndk6 fxv4dng fb1rn9k f59wlhv f1xmfh30 f18yf5o5 fmr6chf fw8qy2q ff161sd f1qr7t77 f1yyogn1 foogchg fp5872b f1tpb8gf f1hdgrc8 f1vatr43 frkxccd f9pdzkb f158oiaz ft5kggy f5l4ui7 f13j03li f18xdoka f8off4e f1go6zfc f128n2ra f1jpxw2j f1lwd9n0 fy0b8hm f1g2633v fx4kvgi fkvolse f1gxrt3a f1os76ua f1js9cnw f1g87ej0 freluf8 f1yggaq6 f2i3chp f1151osp florpoh f35kzfz ftp9m57 f1e288vi fz62hnz fixvuys f1nmofwh fc1c6mv f18a2er7 fhvkrdl fhxnn68 f1oce4bo fvhlfan f7tc0t0 f1ngf1n2 ffrzq6x f1yjiq2m f1aqdgql f1huvaf f10ij78l f1k94sa4 fkmfumq f1jvzkyl f1eu24ob f1xbfc1f fmf0lwf f107dsy8 f3w566c f4648sl f13zpkng f7unjfp f8p1rz fzu6h1w f1i1bi6h f1smo7hi f1sk1xod f1kgogdq f1gjktkp ft608jz f1o9wiiv fg3xr24 fhd155k f1b8gl2e fg4b9ou flb4lo fdicbfk fgwcyh1 f1jbds0d f1fb9uea f1stuka4 fcrtu6g fwqh0xn f11w66yg f6e0e65 f1vvgu0 f1607507 fgct6un f1ec1nbe fg3fpv7 f1m9bycv f1ntoah8 f1b694rt faql4r2 fpjuhzh fmavl6h f1d9bsk fmzhlt0 f145l92p fwkyaqm f129obh1 f19la9g f127w39w fr0ux9m fxhidck f1cu4h9j f1wnbo7v f1eueg4z fy9c24f f1h2o91j f1iw08fq f19n0e5\">\n<p>In pharmacovigilance outsourcing for pharmaceutical companies, the key challenge is not simply delegating operational activities, but maintaining control, traceability, and scientific consistency throughout every step of the process.<\/p>\n<h2>When pharmacovigilance outsourcing creates value<\/h2>\n<p>Outsourcing can involve specific activities, such as case processing, scientific literature monitoring, and follow-up management, or it can extend to the entire pharmacovigilance system.<\/p>\n<p>The main advantage is immediate access to specialized expertise without the need to build and maintain every required role internally. This allows companies to manage workload peaks, new product launches, portfolio expansions, and regulatory changes while maintaining operational continuity and a strong focus on quality.<\/p>\n<p>However, outsourcing does not transfer the Marketing Authorization Holder\u2019s (MAH) ultimate responsibility. The MAH remains accountable for system compliance, supplier oversight, and the adequacy of decisions made.<\/p>\n<p>For this reason, outsourced services must be governed by standard operating procedures, pharmacovigilance agreements, escalation pathways, and measurable performance indicators.<\/p>\n<h2>Pharmacovigilance outsourcing for pharmaceutical companies: choosing the right scope<\/h2>\n<p>The first decision concerns the scope of activities to be outsourced.<\/p>\n<p>A modular model is appropriate when a company already has an established pharmacovigilance function and requires support for specific activities, such as backlog management, product launches, or temporary resource coverage.<\/p>\n<p>A full-service model, on the other hand, may be more suitable when the pharmacovigilance function needs to be established, reorganized, or managed through continuous external support.<\/p>\n<p>Using multiple suppliers for different activities can increase complexity. When Medical Information, scientific literature monitoring, pharmacovigilance, and regulatory affairs operate without a coordinated approach, the risk of duplication, delays, and inconsistent interpretations increases.<\/p>\n<p>A partner with integrated expertise can help reduce these discontinuities while maintaining clear roles, responsibilities, and decision-making boundaries.<\/p>\n<h2>Selection criteria beyond operational capacity<\/h2>\n<p>Resource availability is essential, but it is not sufficient for evaluating a pharmacovigilance provider. In pharmacovigilance, a classification error, inconsistent coding, or incomplete follow-up can lead to regulatory and reputational consequences.<\/p>\n<p>Supplier selection should evaluate at least four key areas:<\/p>\n<ol>\n<li>Demonstrated expertise in products, therapeutic areas, and markets relevant to the company.<\/li>\n<li>Quality of the quality system, including SOPs, training records, deviation management, and CAPA processes.<\/li>\n<li>Ability to manage information flows using validated systems, access controls, and audit trails.<\/li>\n<li>Governance model, including escalation procedures, reporting, KPIs, and support during audits or inspections.<\/li>\n<\/ol>\n<p>It is also important to assess business continuity capabilities. The partner should be able to demonstrate how sudden increases in case volume, system outages, or the absence of key personnel are managed.<\/p>\n<h2>Governance: control cannot be outsourced<\/h2>\n<p>An effective partnership begins before operational activities start. The transition phase should include a structured transfer of information related to products, safety profiles, company procedures, triage criteria, escalation contacts, and system access.<\/p>\n<p>The Safety Data Exchange Agreement (SDEA), or equivalent agreements, should clearly define responsibilities and reporting timelines, avoiding ambiguity in the management of special situations such as medication errors, lack of efficacy cases, or reports originating from non-promotional programs.<\/p>\n<p>Routine governance activities should also monitor timeliness, data completeness, follow-up activities, deviations, quality control, and compliance with reporting requirements.<\/p>\n<p>Every activity must be fully traceable during an audit or inspection through clear evidence, including the source and date of receipt, assessments performed, document versions, approvals, and corrective actions.<\/p>\n<h2>Integrating pharmacovigilance and Medical Information<\/h2>\n<p>The quality of information often depends on the first point of contact.<\/p>\n<p>A Medical Information professional must respond appropriately to a scientific inquiry while also recognizing potential safety information. This requires dedicated training, clear procedures, and timely transfer of safety reports.<\/p>\n<p>Integration between pharmacovigilance, Medical Information, literature research, and medical writing reduces the risk of inconsistent information and improves process continuity.<\/p>\n<p>Outsourcing can therefore strengthen a pharmacovigilance system when the partner operates as a qualified extension of the internal team. Clear roles, transparent processes, and structured governance make it possible to maintain quality, compliance, and control, even during periods of increased operational pressure.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"fai-CopilotMessage__actions rmlvq19 ___7qar2c0 fcthzvy\" role=\"toolbar\" data-tabster=\"{&quot;mover&quot;:{&quot;cyclic&quot;:false,&quot;direction&quot;:2,&quot;memorizeCurrent&quot;:true}}\"><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>A report of a suspected adverse reaction is never just a piece of data to be entered into a system. It may come from a physician, a patient, a digital&#8230;<\/p>\n","protected":false},"author":16,"featured_media":43551,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25,26,4],"tags":[],"class_list":["post-43550","post","type-post","status-publish","format-standard","has-post-thumbnail","category-pharmacovigilance","category-medical-information","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharmacovigilance outsourcing for pharmaceutical companies<\/title>\n<meta name=\"description\" content=\"Pharmacovigilance outsourcing for pharmaceutical companies: key criteria, processes, and controls to ensure compliance, operational continuity, and scientific quality.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacovigilance outsourcing for pharmaceutical companies\" \/>\n<meta property=\"og:description\" content=\"Pharmacovigilance outsourcing for pharmaceutical companies: key criteria, processes, and controls to ensure compliance, operational continuity, and scientific quality.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/\" \/>\n<meta property=\"og:site_name\" content=\"Eureka Info Med\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-03T14:02:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/08\/admin-ajax.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"EleonoraHay\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"EleonoraHay\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\\\/\"},\"author\":{\"name\":\"EleonoraHay\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#\\\/schema\\\/person\\\/a7fea1f3cb636f2ae5986e9a8e805f55\"},\"headline\":\"Pharmacovigilance outsourcing for pharmaceutical companies\",\"datePublished\":\"2026-08-03T14:02:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\\\/\"},\"wordCount\":689,\"image\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/admin-ajax.webp\",\"articleSection\":[\"Pharmacovigilance\",\"Medical Information\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\\\/\",\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\\\/\",\"name\":\"Pharmacovigilance outsourcing for pharmaceutical companies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/admin-ajax.webp\",\"datePublished\":\"2026-08-03T14:02:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#\\\/schema\\\/person\\\/a7fea1f3cb636f2ae5986e9a8e805f55\"},\"description\":\"Pharmacovigilance outsourcing for pharmaceutical companies: key criteria, processes, and controls to ensure compliance, operational continuity, and scientific quality.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/admin-ajax.webp\",\"contentUrl\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/admin-ajax.webp\",\"width\":600,\"height\":400,\"caption\":\"Pharmacovigilance outsourcing for pharmaceutical companies\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmacovigilance outsourcing for pharmaceutical companies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/\",\"name\":\"Eureka Info Med\",\"description\":\"documentazione medico-scientifica e farmacovigilanza\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#\\\/schema\\\/person\\\/a7fea1f3cb636f2ae5986e9a8e805f55\",\"name\":\"EleonoraHay\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g\",\"caption\":\"EleonoraHay\"},\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/author\\\/eleonorahay\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmacovigilance outsourcing for pharmaceutical companies","description":"Pharmacovigilance outsourcing for pharmaceutical companies: key criteria, processes, and controls to ensure compliance, operational continuity, and scientific quality.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/","og_locale":"en_US","og_type":"article","og_title":"Pharmacovigilance outsourcing for pharmaceutical companies","og_description":"Pharmacovigilance outsourcing for pharmaceutical companies: key criteria, processes, and controls to ensure compliance, operational continuity, and scientific quality.","og_url":"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/","og_site_name":"Eureka Info Med","article_published_time":"2026-08-03T14:02:05+00:00","og_image":[{"width":600,"height":400,"url":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/08\/admin-ajax.webp","type":"image\/webp"}],"author":"EleonoraHay","twitter_card":"summary_large_image","twitter_misc":{"Written by":"EleonoraHay","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/#article","isPartOf":{"@id":"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/"},"author":{"name":"EleonoraHay","@id":"https:\/\/eurekainfomed.it\/en\/#\/schema\/person\/a7fea1f3cb636f2ae5986e9a8e805f55"},"headline":"Pharmacovigilance outsourcing for pharmaceutical companies","datePublished":"2026-08-03T14:02:05+00:00","mainEntityOfPage":{"@id":"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/"},"wordCount":689,"image":{"@id":"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/08\/admin-ajax.webp","articleSection":["Pharmacovigilance","Medical Information","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/","url":"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/","name":"Pharmacovigilance outsourcing for pharmaceutical companies","isPartOf":{"@id":"https:\/\/eurekainfomed.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/#primaryimage"},"image":{"@id":"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/08\/admin-ajax.webp","datePublished":"2026-08-03T14:02:05+00:00","author":{"@id":"https:\/\/eurekainfomed.it\/en\/#\/schema\/person\/a7fea1f3cb636f2ae5986e9a8e805f55"},"description":"Pharmacovigilance outsourcing for pharmaceutical companies: key criteria, processes, and controls to ensure compliance, operational continuity, and scientific quality.","breadcrumb":{"@id":"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/#primaryimage","url":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/08\/admin-ajax.webp","contentUrl":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/08\/admin-ajax.webp","width":600,"height":400,"caption":"Pharmacovigilance outsourcing for pharmaceutical companies"},{"@type":"BreadcrumbList","@id":"https:\/\/eurekainfomed.it\/en\/pharmacovigilance-outsourcing-for-pharmaceutical-companies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eurekainfomed.it\/en\/"},{"@type":"ListItem","position":2,"name":"Pharmacovigilance outsourcing for pharmaceutical companies"}]},{"@type":"WebSite","@id":"https:\/\/eurekainfomed.it\/en\/#website","url":"https:\/\/eurekainfomed.it\/en\/","name":"Eureka Info Med","description":"documentazione medico-scientifica e farmacovigilanza","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eurekainfomed.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/eurekainfomed.it\/en\/#\/schema\/person\/a7fea1f3cb636f2ae5986e9a8e805f55","name":"EleonoraHay","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g","caption":"EleonoraHay"},"url":"https:\/\/eurekainfomed.it\/en\/author\/eleonorahay\/"}]}},"_links":{"self":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts\/43550","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/comments?post=43550"}],"version-history":[{"count":1,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts\/43550\/revisions"}],"predecessor-version":[{"id":43552,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts\/43550\/revisions\/43552"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/media\/43551"}],"wp:attachment":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/media?parent=43550"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/categories?post=43550"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/tags?post=43550"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}